Centro de Pesquisa NUPEC - Instituto Orizonti em Belo Horizonte

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Amyloidosis

Running trials

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

  Contact: Trial Manager at Intellia

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis1 recruiting